BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6104790)

  • 21. [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].
    Del Val A; Ponce J; Talens A; Martí-Bonmati L; Garrigues V; Berenguer J
    Rev Esp Enferm Dig; 1991 Mar; 79(3):215-7. PubMed ID: 2043408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary mask of intestinal carcinoid tumor with hypereosinophilic syndrome].
    Shamov IA; Akhmedkhanov SSh; Abdurakhmanova AM
    Sov Med; 1991; (4):91-3. PubMed ID: 1871649
    [No Abstract]   [Full Text] [Related]  

  • 23. Catecholamines and the carcinoid syndrome.
    Cross MH
    Anaesthesia; 1993 Jan; 48(1):81-2. PubMed ID: 8094603
    [No Abstract]   [Full Text] [Related]  

  • 24. Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
    Long RG; Peters JR; Bloom SR; Brown MR; Vale W; Rivier JE; Grahame-Smith DG
    Gut; 1981 Jul; 22(7):549-53. PubMed ID: 6114901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analogs of somatostatin and carcinoid tumors].
    Gutiérrez Rodero F; Morales Cano JM; de Blas Laborda C; González Barber A
    Med Clin (Barc); 1990 Jun; 95(2):78-9. PubMed ID: 2250512
    [No Abstract]   [Full Text] [Related]  

  • 26. Carcinoid syndrome and somatostatin analogues.
    Varas Lorenzo M
    Rev Esp Enferm Dig; 2023 Dec; 115(12):726-727. PubMed ID: 36896924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectopic hormone production in cancer and its implication for basic research on abnormal growth.
    Gellhorn A
    Adv Intern Med; 1969; 15():299-316. PubMed ID: 4314455
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
    Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U
    Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlling the carcinoid syndrome.
    Hodgson HJ
    BMJ; 1988 Nov; 297(6658):1213-4. PubMed ID: 2905181
    [No Abstract]   [Full Text] [Related]  

  • 30. Episodic fevers as a novel feature of the carcinoid syndrome.
    Rondina MT; Fang JC; Yu M
    Am J Clin Oncol; 2008 Dec; 31(6):623. PubMed ID: 19060595
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of a malignant bronchial carcinoid affecting the mediastinum and left atrium by radical two stage resection with cardiopulmonary bypass and somatostatin infusion.
    Darby C; Sinclair M; Westaby S
    Br Heart J; 1990 Jan; 63(1):55-7. PubMed ID: 1968753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peyronie's disease--a presenting complaint of the carcinoid syndrome.
    Bivens CH; Marecek RL; Feldman JM
    N Engl J Med; 1973 Oct; 289(16):844-5. PubMed ID: 4271678
    [No Abstract]   [Full Text] [Related]  

  • 33. [A prolonged-action somatostatin analog and carcinoid syndrome].
    Chayvialle JA
    Bull Acad Natl Med; 1989 May; 173(5):643-50; discussion 650-1. PubMed ID: 2478266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congestive flushes induced by transfusion during a carcinoid syndrome].
    Bletry O; Godeau P; Tard P
    Nouv Presse Med; 1977 Aug 27-Sep 3; 6(28):2522. PubMed ID: 917796
    [No Abstract]   [Full Text] [Related]  

  • 35. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
    Orbach-Zinger S; Lombroso R; Eidelman LA
    Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pellagra and the carcinoid syndrome.
    Castiello RJ; Lynch PJ
    Arch Dermatol; 1972 Apr; 105(4):574-7. PubMed ID: 4259595
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinoid syndrome diagnosed by echocardiography.
    Garg S; Bourantas CV; Nair RK; Alamgir F
    Int J Cardiol; 2011 Feb; 147(1):e1-3. PubMed ID: 19217173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study.
    Halperin DM; Huynh L; Beaumont JL; Cai B; Totev T; Bhak RH; Duh MS; Neary MP; Cella D
    Medicine (Baltimore); 2018 Nov; 97(47):e13390. PubMed ID: 30461659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.